INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS COMPRISING SMALL NUCLEAR RNA (SNRNA) FOR THE TREATMENT OF POMPE DISEASE"

GENEVA, Aug. 6 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/012909) for "COMPOSITIONS AND METHODS COMPRISING SMALL NUCLEAR RNA (SNRNA) FOR THE TREATMENT OF POMPE DISEASE" on Jan 24, 2025. With publication no. WO/2025/160364, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRADFORD, William Henry (c/o Locanabio, Inc.3545 John Hopkins Court, Suite 200San Diego, California 92121), ROTH, Daniela (c/o Locanabio, Inc.3545 John Hopkins Court, Sui...